Hisamitsu, JP3845000001

Hisamitsu stock slips as investors wait for fresh catalysts

Published on 09/05/2026 at 17:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hisamitsu stock stays in view after its latest reported numbers and Tokyo trading context. The Japanese group (ISIN JP3845000001) still offers investors a dated mix of price, valuation, and earnings data.

Hisamitsu, JP3845000001, Illustration mit AI erstellt.
Hisamitsu, JP3845000001, Illustration mit AI erstellt.

Hisamitsu (JP3845000001) stock is in focus after Tokyo trading and the latest reported figures left investors with a clear set of numbers to read. The company posted JPY 94.7 billion in revenue for the first quarter ended May 31, 2026, up 4.8 percent from JPY 90.3 billion a year earlier, while operating profit rose to JPY 13.6 billion from JPY 11.9 billion.

Quarterly numbers still matter

Those first-quarter figures also included net profit of JPY 10.1 billion, compared with JPY 8.8 billion in the same period a year earlier. For investors, the comparison is simple: revenue added JPY 4.4 billion year on year, and operating profit expanded by JPY 1.7 billion.

On the market side, the stock traded at JPY 4,150 on September 4, 2026, with a market capitalization of JPY 521.3 billion and a 52-week range of JPY 3,402 to JPY 4,388. The price sat 5.4 percent below the 52-week high and 22.0 percent above the low.

Latest earnings picture

The most recent operating trend points to a business that is still growing, but not in a straight line. Revenue of JPY 94.7 billion and operating profit of JPY 13.6 billion in the first quarter ended May 31, 2026 give the clearest current snapshot, especially because both figures are newer than full-year comparisons and directly periodized.

Go deeper

Hisamitsu earnings and market data

The latest quarter, the Tokyo price level, and the current valuation frame the stock story in one glance.

Patch still leads sales

Hisamitsu is still best known for its transdermal pain-relief products, and that category remains central to the group's sales mix. The first-quarter numbers show that this product base is still large enough to support JPY 94.7 billion in quarterly revenue while earnings improved year on year.

Tokyo trading level

At JPY 4,150 on September 4, 2026, the stock remained below its 52-week high of JPY 4,388 but well above the low of JPY 3,402. The market therefore assigned the company a valuation of JPY 521.3 billion while waiting for the next earnings step.

Hisamitsu stock facts

  • Company: Hisamitsu Pharmaceutical Co., Inc.
  • ISIN: JP3845000001
  • Ticker: 4530
  • Trading venue: Tokyo Stock Exchange
  • Price (as of September 4, 2026): JPY 4,150
  • Market capitalization: JPY 521.3 billion (as of September 4, 2026)
  • Sector / Industry: Health Care / Pharmaceuticals
  • Index membership: Nikkei 225

Hisamitsu stock on social platforms

Disclaimer...

en | JP3845000001 | HISAMITSU | boerse | 70058198 | bgmi